Results from four separate clinical trials presented at ASCO this year should change clinical practice and could spare many women the side effects of some common cancer therapies.
U.S. National Institutes of Health National Cancer Institute www.cancer.gov
U.S. National Institutes of Health nih.gov
June 21, 2010, 3:03PM
June 7, 2010, 4:49PM
At the opening presidential session of the 2010 annual meeting of the American Society of Clinical Oncology in Chicago, NCI Director John E. Niederhuber, M .D., gave an introduction to James H. Doroshow, M.D., director of NCI’s Division of Cancer Treatment and Diagnosis. It was Dr. Niederhuber’s task to present the multiple achievements that Dr. Doroshow has brought to advancing clinical trial reform and development at NCI.
December 7, 2009, 5:25PM
Colorectal cancer mortality rates have been declining in the last decade. Along with screening, advances in colorectal cancer treatment have played a pivotal role in reducing mortality rates. Surgery, traditional chemotherapy and newer targeted therapies have been important tools in treating this disease.